Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging.
neoplasia
pathology
retina
vitreous
Journal
The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
received:
21
01
2021
accepted:
10
07
2021
pubmed:
4
8
2021
medline:
20
12
2022
entrez:
3
8
2021
Statut:
ppublish
Résumé
To investigate whether the American Joint Committee on Cancer (AJCC) clinical category cT2b needs to be subclassified by the type and distribution of retinoblastoma (RB) seeding. Multicentre, international registry-based data were collected from RB centres enrolled between January 2001 and December 2013. 1054 RB eyes with vitreous or subretinal seeds from 18 ophthalmic oncology centres, in 13 countries within six continents were analysed. Local treatment failure was defined as the use of secondary enucleation or external beam radiation therapy (EBRT) and was estimated with the Kaplan-Meier method. Clinical category cT2b included 1054 eyes. Median age at presentation was 16.0 months. Of these, 428 (40.6%) eyes were salvaged, and 430 (40.8%) were treated with primary and 196 (18.6%) with secondary enucleation. Of the 592 eyes that had complete data for globe salvage analysis, the distribution of seeds was focal in 143 (24.2%) and diffuse in 449 (75.8%). The 5-year Kaplan-Meier cumulative globe-salvage (without EBRT) was 78% and 49% for eyes with focal and diffuse RB seeding, respectively. Cox proportional hazards regression analysis confirmed a higher local treatment failure risk with diffuse seeds as compared with focal seeds (hazard rate: 2.8; p<0.001). There was insufficient evidence to prove or disprove an association between vitreous seed type and local treatment failure risk(p=0.06). This international, multicentre, registry-based analysis of RB eyes affirmed that eyes with diffuse intraocular distribution of RB seeds at diagnosis had a higher risk of local treatment failure when compared with focal seeds. Subclassification of AJCC RB category cT2b into focal vs diffuse seeds will improve prognostication for eye salvage.
Identifiants
pubmed: 34340974
pii: bjophthalmol-2021-318892
doi: 10.1136/bjophthalmol-2021-318892
pmc: PMC9205754
mid: NIHMS1814232
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
127-132Subventions
Organisme : NCI NIH HHS
ID : K08 CA232344
Pays : United States
Investigateurs
Sarah E Coupland
(SE)
Daniel M Albert
(DM)
Anush G Amiryan
(AG)
Svetlana Saakyan
(S)
Claudia Auw-Hädrich
(C)
Diane Baker
(D)
Raymond Barnhill
(R)
José M Caminal
(JM)
William L Caroll
(WL)
Nathalie Cassoux
(N)
Laurence G Desjardins
(LG)
François Doz
(F)
Gaelle Pierron
(G)
Patricia Chévez-Barrios
(P)
R Max Conway
(R)
Bertil E Damato
(BE)
Hakan Demirci
(H)
Jonathan J Dutton
(JJ)
Bita Esmaeli
(B)
Victor G Prieto
(VG)
Michelle Williams
(M)
Brenda L Gallie
(BL)
Gerardo F Graue
(GF)
Hans E Grossniklaus
(HE)
Steffen Heegaard
(S)
Leonard M Holbach
(LM)
Santosh G Honavar
(SG)
Martine J Jager
(MJ)
Emma Kujala
(E)
Livia Lumbroso-Le Rouic
(LL)
Giulio M Modorati
(GM)
Francis L Munier
(FL)
Timothy G Murray
(TG)
Anna C Pavlick
(AC)
Jacob Pe'er
(J)
David E Pelayes
(DE)
Manuel Jorge Rodriguez
(MJ)
Wolfgang Ag Sauerwein
(WA)
Stefan Seregard
(S)
Carol Shields
(C)
E Rand Simpson
(E)
Arun D Singh
(AD)
Shigenobu Suzuki
(S)
Mary Kay Washington
(MK)
Valerie A White
(VA)
Mathew W Wilson
(MW)
Christian W Wittekind
(CW)
Vivian Yin
(V)
Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.